Organogenesis Holdings Inc.

Avista Healthcare Public Acquisition Corp. (AHPA), sponsored by Avista Capital Partners, completed its SPAC initial public offering in 2015, targeting the healthcare and medtech sector. The blank-check company announced a definitive business combination with Organogenesis Holdings Inc., a Massachusetts-based regenerative medicine company specializing in advanced wound care and surgical biologics, in October 2016. The transaction closed, with Organogenesis subsequently listing on Nasdaq under the ticker ORGO. The deal was among the earlier healthcare-focused SPAC combinations of that market cycle, providing Organogenesis with public-market access to accelerate its wound care platform. Sign up at SpacDesk for complete filings, deal timelines, and sponsor analytics on this transaction and thousands more.

SPAC Counterparty (1)